Miquez, Reahlymea .
HRN: 16-73-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/16/2026
03/16/2026
IVT
1g
SD
Stat OR
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines